Literature DB >> 27572459

Fas/FasL gene polymorphism in patients with Hashimoto's thyroiditis in Turkish population.

M Erdogan1, M Kulaksizoglu2, S Ganidagli3, A Berdeli4.   

Abstract

OBJECTIVE: Hashimoto's disease is a polygenic disorder with complex etiopathogenesis. Apoptosis is proposed as one of its mechanisms. The Fas/Fas ligand cascade represents a major pathway initiating apoptosis. This study aims to evaluate the influence of Fas and FasL gene polymorphism in Hashimoto's thyroiditis in Turkish population.
MATERIALS AND METHODS: A total of 112 patients with Hashimoto's thyroiditis and 112 cases of healthy control people were included in this study. The evaluation of genotype for Fas -670 A/G and FasL 843 C/T gene polymorphism was performed by using PCR-RFLP method.
RESULTS: The FAS genotype and gene allele frequency distribution did differ between the control group (AA 36.6 %, AG 50.0 %, GG 13.4 %, A 61.6 %, G 38.4 %) and the Hashimoto's thyroiditis patients (AA 21.4 %, AG 50.9 %, GG 27.7 %, A 46.9 %, G 53.1 %) (p < 0.01). The evaluation of FasL genotype and gene allele frequency did not show statistically significant difference between the patient group (CC 27.7 %, CT 45.5 %, TT 26.8 %, C 50.4 %, T 49.6 %) and control group (CC 33.9 %, CT 44.6 %, TT 21,4 %, C 56.3 %, T 43.8 %) (p > 0.05).
CONCLUSIONS: Gene polymorphism of Fas and G allele frequency may play a role in the regulation of apoptosis in thyroid autoimmune disorders. There is a need for further studies to clarify the genetic role of apoptosis in HT.

Entities:  

Keywords:  Fas/FasL; Gene polymorphism; Hashimoto’s thyroiditis

Mesh:

Substances:

Year:  2016        PMID: 27572459     DOI: 10.1007/s40618-016-0534-5

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  20 in total

1.  Autoimmune thyroid disease in ankylosing spondylitis.

Authors:  Hakan Emmungil; Mehmet Erdogan; Melike Kalfa; Gonca Karabulut; Hayriye Kocanaogulları; Vedat Inal; Kenan Aksu; Fahrettin Oksel; Yasemin Kabasakal; Gokhan Keser
Journal:  Clin Rheumatol       Date:  2014-01-03       Impact factor: 2.980

2.  FAS -670A>G promoter polymorphism is associated with soluble Fas levels in primary Sjögren's syndrome.

Authors:  B A Treviño-Talavera; C A Palafox-Sánchez; J F Muñoz-Valle; G Orozco-Barocio; R E Navarro-Hernández; M Vázquez-Del Mercado; I García de la Torre; E Oregon-Romero
Journal:  Genet Mol Res       Date:  2014-07-02

3.  Association of Fas gene polymorphisms with systemic lupus erythematosus: a meta-analysis.

Authors:  Nan Xiang; Xiao-Mei Li; Guo-Sheng Wang; Jin-Hui Tao; Xiang-Pei Li
Journal:  Mol Biol Rep       Date:  2012-10-13       Impact factor: 2.316

4.  Fas/Fas ligand gene polymorphism in patients with papillary thyroid cancer in the Turkish population.

Authors:  M Erdogan; M Karadeniz; A Berdeli; S Tamsel; Y Ertan; H Uluer; C Yilmaz; M Tuzun; T Kabalak; A G Ozgen
Journal:  J Endocrinol Invest       Date:  2007-05       Impact factor: 4.256

5.  Demographic, clinical, laboratory, ultrasonographic, and cytological features of patients with Hashimoto's thyroiditis: results of a university hospital of 769 patients in Turkey.

Authors:  Mehmet Erdogan; Nihat Erdem; Sevki Cetinkalp; Ahmet Gokhan Ozgen; Fusun Saygılı; Candeger Yilmaz; Mehmet Tuzun; Taylan Kabalak
Journal:  Endocrine       Date:  2009-10-24       Impact factor: 3.633

Review 6.  The association between Cytotoxic T lymphocyte associated antigen-4, Fas, tumour necrosis factor-α gene polymorphisms and autoimmune hepatitis: a meta-analysis.

Authors:  Baodong Qin; Jiangyan Li; Yan Liang; Zaixing Yang; Renqian Zhong
Journal:  Dig Liver Dis       Date:  2014-03-12       Impact factor: 4.088

7.  Increased salivary gland tissue expression of Fas, Fas ligand, cytotoxic T lymphocyte-associated antigen 4, and programmed cell death 1 in primary Sjögren's syndrome.

Authors:  Anne Isine Bolstad; Hans Geir Eiken; Benedikte Rosenlund; Marta E Alarcón-Riquelme; Roland Jonsson
Journal:  Arthritis Rheum       Date:  2003-01

8.  Fas, Fas Ligand, and vitamin D Receptor FokI gene polymorphisms in patients with type 1 diabetes mellitus in the Aegean region of Turkey.

Authors:  Serap Baydur Sahin; Sevki Cetinkalp; Mehmet Erdogan; Candeger Yilmaz; Afig Berdeli
Journal:  Genet Test Mol Biomarkers       Date:  2012-09-04

9.  A functional polymorphism in fas (CD95/APO-1) gene promoter associated with systemic lupus erythematosus.

Authors:  Satomi Kanemitsu; Kenji Ihara; Ahmed Saifddin; Takeshi Otsuka; Tsutomu Takeuchi; Jun Nagayama; Michihiko Kuwano; Toshiro Hara
Journal:  J Rheumatol       Date:  2002-06       Impact factor: 4.666

Review 10.  Fas and Fas ligand-mediated apoptosis and its role in autoimmune diabetes.

Authors:  A Signore; A Annovazzi; R Gradini; R Liddi; G Ruberti
Journal:  Diabetes Metab Rev       Date:  1998-09
View more
  4 in total

1.  Association between FAS gene -670 A/G and -1377 G/A polymorphisms and the risk of autoimmune diseases: a meta-analysis.

Authors:  Hongwei Yan; Yuxiao Hong; Yunfei Cai
Journal:  Biosci Rep       Date:  2020-01-31       Impact factor: 3.840

Review 2.  Genetic Susceptibility to Joint Occurrence of Polycystic Ovary Syndrome and Hashimoto's Thyroiditis: How Far Is Our Understanding?

Authors:  Natalia Zeber-Lubecka; Ewa E Hennig
Journal:  Front Immunol       Date:  2021-02-26       Impact factor: 7.561

3.  How much of the predisposition to Hashimoto's thyroiditis can be explained based on previously reported associations?

Authors:  A Jabrocka-Hybel; A Skalniak; J Piątkowski; R Turek-Jabrocka; P Vyhouskaya; A Ludwig-Słomczyńska; J Machlowska; P Kapusta; M Małecki; D Pach; M Trofimiuk-Müldner; K Lizis-Kolus; A Hubalewska-Dydejczyk
Journal:  J Endocrinol Invest       Date:  2018-06-21       Impact factor: 4.256

Review 4.  ALPS, FAS, and beyond: from inborn errors of immunity to acquired immunodeficiencies.

Authors:  Filippo Consonni; Eleonora Gambineri; Claudio Favre
Journal:  Ann Hematol       Date:  2022-01-20       Impact factor: 3.673

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.